Prostate-Specific Antigen < Prostatectomy < Prostatic Hyperplasia

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 21.
[0-20] [0 - 20][0 - 21][20-20][20-40]

Ident.	Authors (with country if any)	Title
001D73 (2009)		Use of 111in-capromab pendetide immunoscintigraphy to image localized prostate cancer foci within the prostate gland.
002534 (2008)		Use of local (111)in-capromab pendetide scan results to predict outcome after salvage radiotherapy for prostate cancer.
002751 (2007)		The role of indium-111 radioimmunoscintigraphy in post-radical retropubic prostatectomy management of prostate cancer patients.
002885 (2007)		Long-term follow-up of 111In-capromab pendetide (ProstaScint) scan as pretreatment assessment in patients who undergo salvage radiotherapy for rising prostate-specific antigen after radical prostatectomy for prostate cancer.
002C00 (2006)		The impact of a negative (111)indium-capromab pendetide scan before salvage radiotherapy.
002F40 (2005)		Biochemical recurrence after definitive prostate cancer therapy. Part I: defining and localizing biochemical recurrence of prostate cancer.
003174 (2004)		The role of 111indium-capromab pendetide imaging for assessing biochemical failure after radical prostatectomy.
003504 (2003)		Indium-111-capromab pendetide radioimmunoscintigraphy and prognosis for durable biochemical response to salvage radiation therapy in men after failed prostatectomy.
003783 (2002)		Clinical utility of indium 111-capromab pendetide immunoscintigraphy in the detection of early, recurrent prostate carcinoma after radical prostatectomy.
003910 (2001)		The role of imaging studies and molecular markers for selecting candidates for radical prostatectomy.
003A57 (2001)		Utility of capromab pendetide (ProstaScint) imaging in the management of prostate cancer.
003A72 (2001)		PROSTASCINT scan for staging prostate cancer.
003A73 (2001)		Indium-111-capromab pendetide scans: an important test relevant to clinical decision making.
003D74 (1999)		Possible false-positive metastatic prostate cancer on an In-111 capromab pendetide scan as a result of a pelvic kidney.
003D75 (1999)		Indium-111 capromab pendetide (ProstaScint) images before and after salvage radiation therapy.
003F52 (1999)		Using vascular structure for CT-SPECT registration in the pelvis.
004010 (1998)		ProstaScint scan may enhance identification of prostate cancer recurrences after prostatectomy, radiation, or hormone therapy: analysis of 136 scans of 100 patients.
004124 (1998)		Radiolabeled monoclonal antibody indium 111-labeled CYT-356 localizes extraprostatic recurrent carcinoma after prostatectomy.
004128 (1998)		111Indium-capromab pendetide in the evaluation of patients with residual or recurrent prostate cancer after radical prostatectomy. The ProstaScint Study Group.
004212 (1998)		Radioimmunoscintigraphy with In-111-labeled capromab pendetide predicts prostate cancer response to salvage radiotherapy after failed radical prostatectomy.
004944 (1995)		Brachytherapy for prostate cancer: real-time three-dimensional interactive seed implantation.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=IndiumV2/Data/Main/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/MedMesh.i -k "Prostatectomy" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/MedMesh.i  \
                -Sk "Prostatectomy" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=   *** parameter Area/wikiCode missing *** 
   |area=    IndiumV2
   |flux=    Main
   |étape=   Curation
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Prostatectomy
}}

---

This area was generated with Dilib version V0.5.76. Data generation: Tue May 20 07:24:43 2014. Site generation: Thu Mar 7 11:12:53 2024